Safety and Immunogenicity Study of AIDS Vaccine (Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Tiantan)

NCT01705223 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

OTHER_GOV

Sponsor class

Conditions

AIDS

Interventions

BIOLOGICAL: DNA vaccine
BIOLOGICAL: DNA vaccine prime with the addition of electroporation
BIOLOGICAL: rTV boost
BIOLOGICAL: rTV boost
BIOLOGICAL: rTV boost

Sponsor

National Center for AIDS/STD Control and Prevention, China CDC